Proxalutamide Treatment for COVID-19 Patients in Intensive Care Unit
Latest Information Update: 07 Mar 2022
At a glance
- Drugs Pruxelutamide (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
- Sponsors Applied Biology
- 17 Feb 2022 Status changed from recruiting to discontinued. Reason the study was stopped: Sponsor to focus on hospitalised patients
- 29 Apr 2021 New trial record